Liquidia Technologies Correlations

LQDA Stock

USD 15.78 0.66 4.37%

The current 90-days correlation between Liquidia Technologies and Geron is 0.27 (i.e., Modest diversification). The correlation of Liquidia Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Liquidia Technologies Correlation With Market

Very weak diversification

The correlation between Liquidia Technologies and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Liquidia Technologies and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Liquidia Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For information on how to trade Liquidia Stock refer to our How to Trade Liquidia Stock guide.

Moving together with Liquidia Stock

0.79	AZN	AstraZeneca PLC ADR	Pair Corr
0.77	LLY	Eli Lilly	Pair Corr
0.88	PLX	Protalix Biotherapeutics	Pair Corr
0.75	SNY	Sanofi ADR	Pair Corr
0.66	GILD	Gilead Sciences	Pair Corr
0.78	GOSS	Gossamer Bio	Pair Corr
0.85	DRMAW	Dermata Therapeutics	Pair Corr
0.7	NVCT	Nuvectis Pharma	Pair Corr
0.76	AMGN	Amgen Inc	Pair Corr

Moving against Liquidia Stock

0.86	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.86	MRK	Merck Company	Pair Corr
0.82	ZURA	Zura Bio Limited	Pair Corr
0.72	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.65	INBX	Inhibrx Symbol Change	Pair Corr
0.61	IMMX	Immix Biopharma	Pair Corr
0.57	ELVN	Enliven Therapeutics	Pair Corr
0.56	CDIOW	Cardio Diagnostics	Pair Corr
0.52	GPCR	Structure Therapeutics	Pair Corr
0.45	IMRX	Immuneering Corp	Pair Corr
0.34	OCEAW	Ocean Biomedical	Pair Corr
0.8	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.76	CDIO	Cardio Diagnostics	Pair Corr
0.74	BIIB	Biogen Inc	Pair Corr
0.73	CGEM	Cullinan Oncology LLC	Pair Corr
0.72	SCLX	Scilex Holding	Pair Corr
0.71	ATNF	180 Life Sciences	Pair Corr
0.65	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.63	PYXS	Pyxis Oncology	Pair Corr
0.59	AVTE	Aerovate Therapeutics	Pair Corr
0.5	PMVP	Pmv Pharmaceuticals	Pair Corr
0.48	ADVM	Adverum Biotechnologies	Pair Corr
0.46	CNSP	Cns Pharmaceuticals Earnings Call This Week	Pair Corr
0.44	PHIO	Phio Pharmaceuticals Corp Earnings Call This Week	Pair Corr
0.31	CMND	Clearmind Medicine Common	Pair Corr

Related Correlations Analysis

	BMRN	PCVX	LEGN	TECH	UTHR	GERN	NRXP	AGEN	REPL	NVCT
BMRN		-0.85	0.16	-0.8	-0.75	-0.66	-0.42	-0.77	-0.31	0.46	BMRN
PCVX	-0.85		-0.11	0.85	0.84	0.81	0.26	0.76	0.4	-0.49	PCVX
LEGN	0.16	-0.11		-0.41	-0.18	-0.42	-0.19	-0.02	0.57	0.72	LEGN
TECH	-0.8	0.85	-0.41		0.79	0.86	0.41	0.69	0.07	-0.65	TECH
UTHR	-0.75	0.84	-0.18	0.79		0.83	0.32	0.78	0.35	-0.51	UTHR
GERN	-0.66	0.81	-0.42	0.86	0.83		0.13	0.57	0.12	-0.73	GERN
NRXP	-0.42	0.26	-0.19	0.41	0.32	0.13		0.5	-0.17	-0.02	NRXP
AGEN	-0.77	0.76	-0.02	0.69	0.78	0.57	0.5		0.56	-0.4	AGEN
REPL	-0.31	0.4	0.57	0.07	0.35	0.12	-0.17	0.56		0.1	REPL
NVCT	0.46	-0.49	0.72	-0.65	-0.51	-0.73	-0.02	-0.4	0.1		NVCT
	BMRN	PCVX	LEGN	TECH	UTHR	GERN	NRXP	AGEN	REPL	NVCT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GERN	+ 0.86	TECH
TECH	+ 0.85	PCVX
UTHR	+ 0.84	PCVX
GERN	+ 0.83	UTHR
GERN	+ 0.81	PCVX
UTHR	+ 0.79	TECH

High negative correlations

PCVX	- 0.85	BMRN
TECH	- 0.8	BMRN
AGEN	- 0.77	BMRN
UTHR	- 0.75	BMRN
NVCT	- 0.73	GERN
GERN	- 0.66	BMRN

Risk-Adjusted Indicators

There is a big difference between Liquidia Stock performing well and Liquidia Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Liquidia Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BMRN	1.17	0.12	0.10	1.95	1.60	(1.11)	3.04	(3.32)	8.07
PCVX	2.23	(0.12)	0.00	(0.17)	0.00	0.00	3.86	(4.85)	19.90
LEGN	2.39	0.11	0.06	(0.82)	2.76	(2.59)	6.15	(4.66)	14.84
TECH	1.62	(0.26)	0.00	(0.35)	0.00	0.00	3.73	(3.97)	11.29
UTHR	1.52	(0.17)	0.00	(0.46)	0.00	0.00	2.67	(4.23)	15.73
GERN	3.08	(0.94)	0.00	(1.33)	0.00	0.00	4.12	(7.00)	36.19
NRXP	8.64	1.29	0.21	(0.41)	6.60	(11.90)	32.76	(11.97)	63.10
AGEN	4.12	(0.70)	0.00	(0.42)	0.00	0.00	10.48	(8.63)	23.65
REPL	2.83	(0.06)	0.00	(0.11)	0.00	0.00	5.86	(5.88)	22.75
NVCT	4.04	1.31	0.32	8.05	3.53	(4.81)	9.96	(5.84)	26.68

Liquidia Technologies Corporate Management

Jennifer Almond	Director Communications	Profile
Robert Lippe	Chief Operations Officer	Profile
Russell Schundler	General Secretary	Profile
Rajeev MD	Chief Officer	Profile
Ginger Denison	CoFounder	Profile
Roger Jeffs	CEO Director	Profile
Michael Hunter	Senior Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC